If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Eric Morand is Head of the School of Clinical Sciences at Monash Health, Monash University's largest clinical school, and a physician-scientist. 

He specialises in the study of systemic lupus erythematosus. He is founder of the Monash Lupus Clinic, Australia's largest research-grounded clinic for patients with SLE, a founding member of the Australian Lupus Registry & Biobank, and Chair of the Asia-Pacific Lupus Collaboration. His clinical research focuses on improving endpoints for clinical research in lupus. His lab has studied the biology of glucocorticoids in rheumatic disease and lupus since 1996. 

He is a clinical rheumatologist, and Head of the Monash Health Rheumatology Unit, the largest in Australia.

Research interests

Professor Morand is a physician-scientist whose key interests are clinical outcome measurement and biological profiling in SLE, and the actions of glucocorticoid induced proteins on the immune system. Read more at https://www.monash.edu/medicine/scs/researchers/eric-morand .

His group has pioneered the development and validation of treat-to-target outcome measures in SLE, via the Asia-Pacific Lupus Collaboration, which with over 2,800 patients under study is the largest cohort of SLE patients ever assembled. 

Biomarker studies in SLE are also a major focus, with thousands of samples linked to longitudinal clinical data archived in the Australian Lupus Registry & Biobank, headquartered at Monash. 

His lab discovered the role in rheumatic disease of multiple important glucocorticoid-regulated proteins. Most recently his group defined the role of GILZ in RA, Th17 pathways, B cell activation, and lupus, and are working on exploiting its actions to develop a safe glucocorticoid mimic. His lab also works on innate immunity including the actions of the unique pro-inflammatory protein, MIF. 

Clinical activities

Professor Morand is Head of Rheumatology, Monash Health. He works in clinics servicing lupus, rheumatoid arthritis, and complex rheumatology cases, and undertakes ward duty inpatient care in the largest service in the country. 


Advisory expertise and research collaboration experience with international biotech and Pharma companies. 


Special interests include Lupus / SLE outcome measures, trials, translational research and biomarkers. 

Community service

Professor Morand is a Board member of Rare Voices Australia, has served on the board of the Australian Rheumatology Association and is a member of the Scientific Advisory Board of the ARA Research Trust. 

Research area keywords

  • Systemic Lupus Erythematosus
  • glucocorticoids
  • Lupus
  • SLE
  • RA
  • GILZ
  • MIF
  • Rheumatoid Arthritis
  • Rheumatology
  • outcome measures
  • Clinical Trials
  • Translational Research
  • Cytokines

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Assays for Inducing and Measuring Cell Death to Detect Macrophage Migration Inhibitory Factor (MIF) Release

Zamani, S., Morand, E. F. & Flynn, J. K., 1 Jan 2020, In : Methods in molecular biology (Clifton, N.J.). 2080, p. 173-183 11 p.

Research output: Contribution to journalArticleOtherpeer-review

Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses

Pépin, G., De Nardo, D., Rootes, C. L., Ullah, T. R., Al-Asmari, S. S., Balka, K. R., Li, H-M., Quinn, K. M., Moghaddas, F., Chappaz, S., Kile, B. T., Morand, E. F., Masters, S. L., Stewart, C. R., Williams, B. R. G. & Gantier, M. P., 28 Jan 2020, In : mBio. 11, 1, 6 p., e03187-19.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Apostolopoulos, D., Kandane-Rathnayake, R., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Golder, V., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Lau, C. S., Li, Z. G., Hoi, A., Nikpour, M. & 2 others, Morand, E. F. & for the Asia Pacific Lupus Collaboration, Jan 2020, In : The Lancet Rheumatology. 2, 1, p. e24-e30 7 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity

Zhan, Y., Kong, I., Chopin, M., Macri, C., Zhang, J. G., Xie, J., Nutt, S. L., O'Keeffe, M., Hawkins, E. D., Morand, E. F. & Lew, A. M., 9 Jan 2020, (Accepted/In press) In : Immunology and Cell Biology. 12 p.

Research output: Contribution to journalArticleResearchpeer-review


Dean's Award for Research (Enterprise)

Eric Morand (Recipient), 1 Aug 2018

Prize: Prize (including medals and awards)

Distinguished Innovator Award, Lupus Research Alliance

Eric Morand (Recipient), 2015

Prize: National/international honour

Paper selected for the Best of Immunology & Cell Biology (ICB)/ Clinical and Translational Immunology (CTI) Workshop at the 2019 Australian & New Zealand Society for Immunology (ASI) Annual Scientific Meeting

Fabien Vincent (Recipient), James Harris (Recipient), Eric Morand (Recipient), Joanne Sahhar (Recipient), Gene Ngian (Recipient), Rangi Kandane-Rathnayake (Recipient), Tali Lang (Recipient), Emily Lin (Recipient) & Rachel Mende (Recipient), 11 Dec 2019

Prize: Prize (including medals and awards)

Parr Prize for Research, Australian Rheumatology Association

Eric Morand (Recipient), 2001

Prize: Prize (including medals and awards)

Supervisor of the Year

Eric Morand (Recipient), 2011

Prize: Prize (including medals and awards)